Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Deferred Taxes (2020 - 2025)

Historic Deferred Taxes for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $135000.0.

  • Bioventus' Deferred Taxes rose 12641.88% to $135000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 14615.9%. This contributed to the annual value of -$5.4 million for FY2024, which is 12692.47% down from last year.
  • According to the latest figures from Q3 2025, Bioventus' Deferred Taxes is $135000.0, which was up 12641.88% from $44000.0 recorded in Q2 2025.
  • Bioventus' Deferred Taxes' 5-year high stood at $3.2 million during Q4 2024, with a 5-year trough of -$17.0 million in Q2 2022.
  • For the 5-year period, Bioventus' Deferred Taxes averaged around -$3.6 million, with its median value being -$799000.0 (2021).
  • In the last 5 years, Bioventus' Deferred Taxes crashed by 2060361.45% in 2022 and then soared by 17644.02% in 2024.
  • Over the past 5 years, Bioventus' Deferred Taxes (Quarter) stood at -$8.1 million in 2021, then plummeted by 46.14% to -$11.8 million in 2022, then skyrocketed by 109.88% to $1.2 million in 2023, then skyrocketed by 176.44% to $3.2 million in 2024, then plummeted by 95.8% to $135000.0 in 2025.
  • Its Deferred Taxes was $135000.0 in Q3 2025, compared to $44000.0 in Q2 2025 and $43000.0 in Q1 2025.